Vitrolife AB operates within the Surgical appliances and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vitrolife AB with three other
medical equipment manufacturers in Europe:
IVF Hartmann Holding AG
sales of 138.00 million Swiss Francs [US$155.40 million]
of which 38%
was Infections Management),
(150.46 million Euros [US$182.60 million]
of which 100%
was Medical/Hospitality), and
Medartis Holding AG
based in SWITZERLAND
(130.14 million Swiss Francs [US$146.56 million]
of which 54%
During the year ended December of 2019, sales at
Vitrolife AB were SEK 1.48 billion (US$178.70 million).
increase of 28.6%
versus 2018, when the company's sales were SEK 1.15 billion.
This was the fifth consecutive year of sales increases at Vitrolife AB
(and since 2014, sales have increased a total of 190%).
Sales of Time-Lapse saw an increase
45.1% in 2019, from
SEK 297.00 million to SEK 431.00 million.